Citadel Advisors - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is and the CUSIP is 67424L209. A total of 15 filers reported holding OBALON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$110,000
-3.5%
38,903
-49.0%
0.00%
Q4 2020$114,000
+442.9%
76,253
+226.5%
0.00%
Q3 2020$21,000
-22.2%
23,353
-39.0%
0.00%
Q2 2020$27,000
+3.8%
38,296
+187.7%
0.00%
Q3 2019$26,00013,3110.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 380,224$346,0000.10%
ARMISTICE CAPITAL, LLC 740,000$674,0000.02%
Cerity Partners LLC 155,000$141,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 33,000$30,0000.00%
WELLS FARGO & COMPANY/MN 40$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 332$00.00%
GEODE CAPITAL MANAGEMENT, LLC 11,709$10,0000.00%
CITIGROUP INC 500$00.00%
MORGAN STANLEY 700,010$637,0000.00%
View complete list of OBALON THERAPEUTICS INC shareholders